Notis McConarty Edward acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, Holdings Channel reports. The firm acquired 10,150 shares of the company’s stock, valued at approximately $1,304,000.
A number of other hedge funds have also made changes to their positions in MKGAF. Great Lakes Advisors LLC acquired a new position in shares of Merck KGaA during the 2nd quarter valued at $183,444,000. BOK Financial Private Wealth Inc. acquired a new stake in Merck KGaA in the 2nd quarter valued at $523,000. Bell & Brown Wealth Advisors LLC acquired a new stake in Merck KGaA in the 2nd quarter valued at $5,662,000. Asahi Life Asset Management CO. LTD. purchased a new position in Merck KGaA in the second quarter valued at about $1,168,000. Finally, Avaii Wealth Management LLC purchased a new position in Merck KGaA in the second quarter valued at about $1,573,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 4.5%
Shares of MKGAF opened at $167.38 on Thursday. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The stock’s 50-day moving average is $162.50 and its two-hundred day moving average is $148.28. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a market cap of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
